Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125052432 | 12505243 | 2 | F | 2016 | 20160704 | 20160628 | 20160713 | EXP | GB-PFIZER INC-2016304712 | PFIZER | 42.00 | YR | F | Y | 0.00000 | 20160713 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125052432 | 12505243 | 1 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | CYCLIC: EVERY THREE WEEKS | U | 0 | ||||||||||
| 125052432 | 12505243 | 2 | PS | DOCETAXEL. | DOCETAXEL | 1 | UNK, 3 CYCLES | U | 202356 | ||||||||||
| 125052432 | 12505243 | 3 | SS | EPIRUBICIN HCL | EPIRUBICIN HYDROCHLORIDE | 1 | UNK, CYCLIC: EVERY THREE WEEKS | U | 50778 | ||||||||||
| 125052432 | 12505243 | 4 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | UNK, CYCLIC: EVERY THREE WEEKS | U | 0 | ||||||||||
| 125052432 | 12505243 | 5 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 2 MG, 1X/DAY (FOR 3 DAYS ) | U | 0 | 2 | MG | QD | ||||||
| 125052432 | 12505243 | 6 | SS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, 24 HOURS AFTER CHEMOTHERAPY | U | 0 | 6 | MG | |||||||
| 125052432 | 12505243 | 7 | SS | APREPITANT. | APREPITANT | 1 | Oral | 80 MG, ONCE A DAY (TAKEN ON DAY 2 AND 3 AFTER CHEMOTHERAPY) | U | 0 | 80 | MG | QD | ||||||
| 125052432 | 12505243 | 8 | SS | LEVOMEPROMAZINE | LEVOMEPROMAZINE | 1 | UNK | U | 0 | ||||||||||
| 125052432 | 12505243 | 9 | SS | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | UNK | U | 0 | ||||||||||
| 125052432 | 12505243 | 10 | SS | ONDANSETRON | ONDANSETRON | 1 | UNK | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125052432 | 12505243 | OT |
| 125052432 | 12505243 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125052432 | 12505243 | Arthralgia | |
| 125052432 | 12505243 | Constipation | |
| 125052432 | 12505243 | Decreased appetite | |
| 125052432 | 12505243 | Deep vein thrombosis | |
| 125052432 | 12505243 | Fatigue | |
| 125052432 | 12505243 | Oral pain | |
| 125052432 | 12505243 | Pain | |
| 125052432 | 12505243 | Pain in extremity | |
| 125052432 | 12505243 | Peripheral swelling | |
| 125052432 | 12505243 | Vascular pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |